Ignite Creation Date:
2025-12-24 @ 10:21 PM
Ignite Modification Date:
2026-01-03 @ 8:00 PM
Study NCT ID:
NCT00951535
Status:
UNKNOWN
Last Update Posted:
2023-04-06
First Post:
2009-08-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer. ICORG 08-17
Sponsor:
Cancer Trials Ireland
Organization:
Organization Data
Organization:
Class:
NETWORK
Study ID:
08-17 ICORG
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None